CSPN, Dara BioSciences enter distribution contract for breast cancer drug

CSPN to distribute Soltamox

DREXEL HILL, Pa. — The Community Specialty Pharmacy Network has entered a contract with Dara BioSciences to distribute a nonsteroidal anti-estrogen product.

CSPN announced the agreement with Dara to distribute Soltamox (tamoxifen) solution for oral administration. The drug, a treatment for breast cancer, is for patients who have difficulty swallowing pills.

"Compliance and adherence to prescribed tamoxifen therapy is a critical issue in patient care and may affect treatment outcomes," Dara BioSciences VP sales, marketing and business development David Benharris said. "Soltamox provides a unique treatment option for those patients with swallowing difficulties or who simply prefer an oral liquid over tablet or pills."

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

Login or Register to post a comment.